Navtemadlin and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma

PHASE1CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

June 20, 2018

Primary Completion Date

August 27, 2023

Study Completion Date

September 4, 2025

Conditions
Resectable Soft Tissue SarcomaSoft Tissue Sarcoma
Interventions
DRUG

Navtemadlin

Given PO

RADIATION

Radiation Therapy

Undergo radiation therapy

PROCEDURE

Surgical Procedure

Undergo surgery

Trial Locations (53)

10032

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York

14263

Roswell Park Cancer Institute, Buffalo

15232

UPMC-Shadyside Hospital, Pittsburgh

19107

Thomas Jefferson University Hospital, Philadelphia

19111

Fox Chase Cancer Center, Philadelphia

19124

Eastern Regional Medical Center, Philadelphia

27599

UNC Lineberger Comprehensive Cancer Center, Chapel Hill

30265

CTCA at Southeastern Regional Medical Center, Newnan

30308

Emory University Hospital Midtown, Atlanta

30322

Emory University Hospital/Winship Cancer Institute, Atlanta

30342

Northside Hospital, Atlanta

40202

The James Graham Brown Cancer Center at University of Louisville, Louisville

43210

Ohio State University Comprehensive Cancer Center, Columbus

53022

Aurora Health Care Germantown Health Center, Germantown

53024

Aurora Cancer Care-Grafton, Grafton

53066

Aurora Medical Center in Summit, Summit

53081

Vince Lombardi Cancer Clinic-Sheboygan, Sheboygan

53105

Aurora Cancer Care-Southern Lakes VLCC, Burlington

53142

Aurora Cancer Care-Kenosha South, Kenosha

53209

Aurora Cancer Care-Milwaukee, Milwaukee

53215

Aurora Saint Luke's Medical Center, Milwaukee

53226

Aurora Cancer Care-Milwaukee West, Wauwatosa

53227

Aurora West Allis Medical Center, West Allis

53233

Aurora Sinai Medical Center, Milwaukee

53406

Aurora Cancer Care-Racine, Racine

53792

University of Wisconsin Carbone Cancer Center - University Hospital, Madison

54143

Aurora Bay Area Medical Group-Marinette, Marinette

54241

Vince Lombardi Cancer Clinic-Two Rivers, Two Rivers

54311

Aurora BayCare Medical Center, Green Bay

54904

Vince Lombardi Cancer Clinic - Oshkosh, Oshkosh

54937

Aurora Health Center-Fond du Lac, Fond du Lac

55905

Mayo Clinic in Rochester, Rochester

59405

Benefis Sletten Cancer Institute, Great Falls

59901

Logan Health Medical Center, Kalispell

60611

Northwestern University, Chicago

60612

Rush University Medical Center, Chicago

63110

Washington University School of Medicine, St Louis

63129

Siteman Cancer Center-South County, St Louis

63141

Siteman Cancer Center at West County Hospital, Creve Coeur

66210

University of Kansas Cancer Center-Overland Park, Overland Park

68114

Nebraska Methodist Hospital, Omaha

73104

University of Oklahoma Health Sciences Center, Oklahoma City

75235

Parkland Memorial Hospital, Dallas

75390

UT Southwestern/Simmons Cancer Center-Dallas, Dallas

80045

UCHealth University of Colorado Hospital, Aurora

80524

Poudre Valley Hospital, Fort Collins

83706

Saint Alphonsus Cancer Care Center-Boise, Boise

85054

Mayo Clinic Hospital in Arizona, Phoenix

85259

Mayo Clinic in Arizona, Scottsdale

85338

CTCA at Western Regional Medical Center, Goodyear

85704

University of Arizona Cancer Center-Orange Grove Campus, Tucson

85719

University of Arizona Cancer Center-North Campus, Tucson

08903

Rutgers Cancer Institute of New Jersey, New Brunswick

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

NRG Oncology

OTHER

lead

National Cancer Institute (NCI)

NIH

NCT03217266 - Navtemadlin and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma | Biotech Hunter | Biotech Hunter